What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News FDA sets review date for Ironshore Pharmaceuticals’ ADHD drug HLD200 Ironshore Pharmaceuticals & Development, a subsidiary of Highland Therapeutics, has reached a significant milestone with the U.S. Food… bypharmanewsdailyJuly 15, 2018
